Recombinant Probiotics for Treatment and Prevention of Enterotoxigenic Escherichia coli Diarrhea

This publication has 32 references indexed in Scilit:

• Peripheral neuropathies and anti-glycolipid antibodies
  Brain, 2002
• Oral Administration of Formaldehyde-Killed Recombinant Bacteria Expressing a Mimic of the Shiga Toxin Receptor Protects Mice from Fatal Challenge with Shiga-Toxigenic Escherichia coli
  Infection and Immunity, 2001
• A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans
  Nature Medicine, 2000
• Novel Carbohydrate Binding Site Recognizing Blood Group A and B Determinants in a Hybrid of Cholera Toxin and Escherichia coli Heat-labile Enterotoxin B-subunits
  Journal of Biological Chemistry, 2000
• Meaning and therapeutic potential of microbial recognition of host glycoconjugates
  Molecular Microbiology, 1998
• DiarrheagenicEscherichia coli
  Clinical Microbiology Reviews, 1998
• Delineation and comparison of ganglioside-binding epitopes for the toxins of Vibrio cholerae, Escherichia coli, and Clostridium tetani: evidence for overlapping epitopes.
  Proceedings of the National Academy of Sciences, 1994
• Travelers' Diarrhea: Approaches to Prevention and Treatment
  Clinical Infectious Diseases, 1993
• Traveller's diarrhea among Austrian tourists in warm climate countries: I. Epidemiology
  European Journal of Epidemiology, 1989
• Epidemiologic Studies of Travelers' Diarrhea, Severe Gastrointestinal Infections, and Cholera
  Clinical Infectious Diseases, 1986